Adicet Bio, Inc. — Director's Dealing 2020

Oct 29, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Adicet Bio, Inc. (ACET)
CIK: 0001720580
Period of Report: 2020-10-27

Reporting Person: Healey Don (Chief Technology Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-10-27	Non-Qualified Option (right to buy)	$12.23	A	166605	Acquired	2030-10-26	Common Stock (166605)	Direct

Footnotes

F1: 25% of the shares of common stock subject to the option shall vest on October 27, 2021, and 1/36th of the remaining unvested shares subject to the option shall vest on each of the next thirty-six (36) monthly anniversaries of the vesting commencement date thereafter.